Development of the PHASE-Proxy scale for rating drug-related signs and symptoms in severe cognitive impairment.

Mariann HedströmMarianne CarlssonAnna EkmanUlrika GillespieChristina MörkKerstin Hulter Åsberg

Published in: Aging & mental health (2016)

The PHASE-Proxy scale appears to be a valid instrument that enables proxies to reliably assess nursing home residents who cannot participate in the assessment, to identify possible drug-related signs and symptoms. It also appears to be clinically useful and feasible for use in this population.

Keyphrases

cognitive impairment
drug induced
early onset
adverse drug
emergency department
physical activity
depressive symptoms
patient reported outcomes
clinical evaluation